{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:54:41Z","timestamp":1757616881415,"version":"3.44.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13193-024-02148-w","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:02:17Z","timestamp":1733446937000},"page":"813-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant Chemotherapy with Low-Dose Nivolumab Leading to Complete Pathological Response in Non-small Cell Lung Carcinoma"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-5056","authenticated-orcid":false,"given":"Prasanth","family":"Penumadu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanapathi","family":"Halanaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"21","key":"2148_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM et al (2022) Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med 386(21):1973\u20131985","journal-title":"N Engl J Med"},{"issue":"3","key":"2148_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2148_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jtho.2021.02.004","volume":"16","author":"N Singh","year":"2021","unstructured":"Singh N, Agrawal S, Jiwnani S, Khosla D, Malik PS, Mohan A et al (2021) Lung cancer in India. J Thorac Oncol 16(8):1250\u20131266","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2148_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000332","volume":"3","author":"SH Yoo","year":"2018","unstructured":"Yoo SH, Keam B, Kim M, Kim SH, Kim YJ, Kim TM et al (2018) Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity. ESMO Open 3(5):e000332","journal-title":"ESMO Open"},{"issue":"2","key":"2148_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4103\/CRST.CRST_82_19","volume":"2","author":"V Talreja","year":"2019","unstructured":"Talreja V, Noronha V, Patil V, Joshi A, Prabhash K (2019) Desperate times, desperate measures: low-dose nivolumab-induced remission in relapsed NSCLC. Cancer Res Stat Treat 2(2):266","journal-title":"Cancer Res Stat Treat"},{"issue":"2","key":"2148_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.22.01015","volume":"41","author":"VM Patil","year":"2023","unstructured":"Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A et al (2023) Low-dose immunotherapy in head and neck cancer: a randomized study. J Clin Oncol Off J Am Soc Clin Oncol 41(2):222\u2013232","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-024-02148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-024-02148-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-024-02148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:05:03Z","timestamp":1757106303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-024-02148-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s13193-024-02148-w","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"type":"print","value":"0975-7651"},{"type":"electronic","value":"0976-6952"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not applicable for this report as the patient identifiers have not been revealed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Consent was obtained from the patient for an off-label indication of low-dose nivolumab and also reported this case in scientific journals. The identity of the patient is not revealed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Dr. Prasanth Penumadu is a Section Editor in the Indian Journal of Surgical Oncology. The other authors declare that they have no competing financial or personal relationships that could have influenced this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}